Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden

Vaccine. 2018 Apr 5;36(15):1917-1920. doi: 10.1016/j.vaccine.2018.02.097. Epub 2018 Mar 6.

Abstract

Background: Between 2007 and 2011, opportunistic HPV-vaccination was available in Sweden and partially subsidized to girls aged 13-17, reaching a ∼30% overall coverage.

Methods: All Swedish women/men aged 15-44 were followed between 2006 and 2012 for condyloma. Average annual percent changes (AAPCs) in incidence were estimated.

Results: Substantial decreases were seen in women aged 15-24 from 2008-onwards (AACP-range: -8.5% to -18.5%); similar effects were seen for men aged 15-29 (AACP-range: -7.0% to -16.6%) from 2010-onwards.

Discussion: Despite low population vaccination coverage in women and no coverage in men, similar condyloma incidence reductions were observed among men and women, with delays of >1 years in men.

Keywords: Condyloma; HPV; Population-level; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Cohort Studies
  • Condylomata Acuminata / epidemiology*
  • Condylomata Acuminata / prevention & control*
  • Female
  • Humans
  • Incidence
  • Male
  • Outcome Assessment, Health Care
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / administration & dosage
  • Papillomavirus Vaccines / immunology*
  • Population Surveillance
  • Sweden / epidemiology
  • Time Factors
  • Vaccination
  • Vaccination Coverage
  • Young Adult

Substances

  • Papillomavirus Vaccines